imatinib mesylate has been researched along with Nephrogenic Systemic Fibrosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chandran, S; Doeden, K; Fiorentino, D; Jacobs, C; Lafayette, RA; Petersen, J | 1 |
| Elmholdt, TR; Jørgensen, B; Olesen, AB; Pedersen, M; Ramsing, M | 1 |
| Buus, NH; Elmholdt, TR; Olesen, AB; Ramsing, M | 1 |
| Brasch, RC; Fu, Y; High, WA; Hope, TA; Leboit, PE | 1 |
1 trial(s) available for imatinib mesylate and Nephrogenic Systemic Fibrosis
| Article | Year |
|---|---|
Antifibrotic effect after low-dose imatinib mesylate treatment in patients with nephrogenic systemic fibrosis: an open-label non-randomized, uncontrolled clinical trial.
Topics: Adult; Benzamides; Female; Humans; Imatinib Mesylate; Male; Middle Aged; Nephrogenic Fibrosing Dermopathy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Severity of Illness Index | 2013 |
3 other study(ies) available for imatinib mesylate and Nephrogenic Systemic Fibrosis
| Article | Year |
|---|---|
Imatinib in the treatment of nephrogenic systemic fibrosis.
Topics: Benzamides; Contrast Media; Female; Gadolinium; Humans; Imatinib Mesylate; Kidney Failure, Chronic; Middle Aged; Nephrogenic Fibrosing Dermopathy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Renal Dialysis | 2009 |
Positive effect of low-dose imatinib mesylate in a patient with nephrogenic systemic fibrosis.
Topics: Adult; Benzamides; Humans; Imatinib Mesylate; Joints; Male; Nephrogenic Fibrosing Dermopathy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Range of Motion, Articular; Recovery of Function; Severity of Illness Index; Skin; Time Factors; Treatment Outcome | 2011 |
Evaluation of imatinib mesylate as a possible treatment for nephrogenic systemic fibrosis in a rat model.
Topics: Animals; Benzamides; Contrast Media; Gadolinium DTPA; Imatinib Mesylate; Male; Nephrogenic Fibrosing Dermopathy; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Rats; Rats, Wistar; Treatment Outcome | 2013 |